Invention Application
- Patent Title: FUSED AZEPINONE CYCLIN DEPENDENT KINASE INHIBITORS
- Patent Title (中): 融合AZEPINONE CYCLIN依赖性激酶抑制剂
-
Application No.: PCT/US9913579Application Date: 1999-06-16
-
Publication No.: WO9965910A9Publication Date: 2000-03-16
- Inventor: KUNICK CONRAD , MEIJER LAURENT , ZAHAREVITZ DANIEL W , GUSSIO RICK , JALLURI RAVI K , SAUSVILLE EDWARD A
- Applicant: US HEALTH , KUNICK CONRAD , MEIJER LAURENT , ZAHAREVITZ DANIEL W , GUSSIO RICK , JALLURI RAVI K , SAUSVILLE EDWARD A
- Assignee: US HEALTH,KUNICK CONRAD,MEIJER LAURENT,ZAHAREVITZ DANIEL W,GUSSIO RICK,JALLURI RAVI K,SAUSVILLE EDWARD A
- Current Assignee: US HEALTH,KUNICK CONRAD,MEIJER LAURENT,ZAHAREVITZ DANIEL W,GUSSIO RICK,JALLURI RAVI K,SAUSVILLE EDWARD A
- Priority: US8961998 1998-06-16
- Main IPC: A61K31/55
- IPC: A61K31/55 ; A61P35/00 ; A61P43/00 ; C07D471/04 ; C07D471/14 ; C07D487/04 ; C07D487/14 ; C07D495/14
Abstract:
A new class of cyclin dependent kinase inhibitors that also have antiproliferative activity in human tumor cell line assays are described. Most of these compounds satisfy formula (I); wherein A is oxygen or sulfur coupled to the right by a single or double bond; R>2 4 7 8 11 12
Information query